T

Bio-Techne Corp
D

TECH

50.350
USD
-0.19
(-0.38%)
Market Open
Volume
36,965
EPS
2
Div Yield
0.64
P/E
51
Market Cap
7,954,181,770
Related Instruments
AAPL
AAPL
-3.640
(-1.79%)
200.330 USD
AMD
AMD
2.990
(3.05%)
101.235 USD
AMZN
AMZN
0.540
(0.29%)
187.590 USD
GOOGL
GOOGL
2.060
(1.26%)
164.770 USD
INTC
INTC
-0.015
(-0.07%)
20.330 USD
MSFT
MSFT
8.00
(1.86%)
438.94 USD
NFLX
NFLX
22.12
(1.98%)
1,137.72 USD
NVDA
NVDA
0.840
(0.74%)
114.000 USD
TSLA
TSLA
-6.10
(-2.13%)
279.97 USD
More
News

Title: Bio/Techne Corp

Sector: Healthcare
Industry: Biotechnology
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of theworld accounting for the remaining 5%.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.